SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Clomipramine in Obsessive-Compulsive Disorder
14 references·16 citing·38 second hop
Clomipramine in Obsessive-Compulsive Disorder (1989)Clomipramine in Obsessive-Compulsive Diso…Obsessive Compulsive Disorder (2022)Obsessive Compulsive DisorderSerotonin Function in Obsessive-Compulsive Disorder (1988)Serotonin Function in Obsessi…Serotonergic Responsivity in Obsessive-Compulsive Disorder (1988)Serotonergic Responsivity in …Serotonergic Responsivity in Obsessive-Compulsive Disorder (1987)Serotonergic Responsivity in …Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology (1987)Obsessive-compulsive disorder…Fluvoxamine treatment of obsessive-compulsive disorder (1987)Fluvoxamine treatment of obse…Biochemical Changes During Clomipramine Treatment of Childhood Obsessive-Compulsive Disorder (1987)Biochemical Changes During Cl…The Influence of Ritanserin, a Serotonin Antagonist, in Anxiety Disorders: A Double-blind Placebo-controlled Study versus Lorazepam (1985)The Influence of Ritanserin, …Fluoxetine Treatment of Obsessive-Compulsive Disorder (1985)Fluoxetine Treatment of Obses…Clomipramine Treatment of Childhood Obsessive-Compulsive Disorder (1985)Clomipramine Treatment of Chi…Buspirone and diazepam in anxiety: a controlled study. (1982)Buspirone and diazepam in anx…Clomipramine Treatment of Obsessive-Compulsive Disorder (1980)Clomipramine Treatment of Obs…Clomipramine Treatment of Obsessive-Compulsive Disorder (1980)Clomipramine Treatment of Obs…A COMPREHENSIVE PSYCHOPATHOLOGICAL RATING SCALE (1978)A COMPREHENSIVE PSYCHOPATHOLO…Pharmacotherapy for trichotillomania (2013)Pharmacotherapy for trichotil…Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorder (2006)Mechanisms of action of curre…Efficacy of Fluvoxamine, Paroxetine, and Citalopram in the Treatment of Obsessive-Compulsive Disorder (1997)Efficacy of Fluvoxamine, Paro…Normal Caudate Nucleus in Obsessive-compulsive Disorder Assessed by Quantitative Neuroimaging (1996)Normal Caudate Nucleus in Obs…Alteration of Serotonin Release in the Guinea Pig Orbito-Frontal Cortex by Selective Serotonin Reuptake Inhibitors Relevance to Treatment of Obsessive-Compulsive Disorder (1995)Alteration of Serotonin Relea…Tryptophan Depletion in Patients With Obsessive-Compulsive Disorder Who Respond to Serotonin Reuptake Inhibitors (1994)Tryptophan Depletion in Patie…Obsessive‐Compulsive Disorder (1994)Obsessive‐Compulsive DisorderCocaine use and other suspected risk factors for obsessive-compulsive disorder: a prospective study with data from the Epidemiologic Catchment Area surveys (1993)Cocaine use and other suspect…A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to IV mCPP (1993)A comparison of the behaviora…Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder (1992)Peripheral markers of seroton…Neuroendocrine Responses to m-Chlorophenylpiperazine and i-Tryptophan in Bulimia (1992)Neuroendocrine Responses to m…Neurobiology of Obsessive Compulsive Disorder (1992)Neurobiology of Obsessive Com…Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder (1991)Metergoline blocks the behavi…Kleptomania: clinical characteristics and associated psychopathology (1991)Kleptomania: clinical charact…Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chloro-phenylpiperazine in obsessive-compulsive disorder (1991)Effects of chronic fluoxetine…Obsessive—Compulsive Disorder as a 5-HT Subsystem-Related Behavioural Disorder (1989)Obsessive—Compulsive Disorder…The Brief Psychiatric Rating Scale (1962)The Leyton Obsessional Inventory (1970)Lust, attraction, and attachment in mammalian reproduction (1998)Sertraline in Children and Adolescents With Obsessive-Compulsive Disorder (1998)Which SSRI? A Meta-Analysis of Pharmacotherapy Trials in Pediatric Obsessive-Compulsive Disorder (2003)A RATING SCALE FOR DEPRESSION (1960)5-HIAA in the Cerebrospinal Fluid (1976)Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites (1984)Controlled Comparisons of Clomipramine and Fluoxetine in the Treatment of Obsessive-Compulsive Disorder (1990)Elevated Cerebrospinal Fluid Levels of Oxytocin in Obsessive-compulsive Disorder (1994)Obsessive-Compulsive Disorder (2014)Development of a Rating Scale for Primary Depressive Illness (1967)Exclusion Criteria of DSM-III (1984)Efficacy of Fluvoxamine in Obsessive-Compulsive Disorder (1989)Toward a Neurodevelopmental Model of Obsessive–Compulsive Disorder (1998)Clomipramine and Exposure for Obsessive-Compulsive Rituals: 1 (1980)Altered Serotonin Activity in Anorexia Nervosa After Long-term Weight Restoration (1991)Serotonergic Function in Obsessive-Compulsive Disorder (1992)A meta-analysis on the treatment of obsessive compulsive disorder: A comparison of antidepressants, behavior, and cognitive therapy (1994)Research Diagnostic Criteria (1978)A New Depression Scale Designed to be Sensitive to Change (1979)Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: A quantitative Review. (1997)A comparison between the Beck Depression Inventory (BDI) and the self-rating version of the Montgomery Åsberg Depression Rating Scale (MADRS) (2001)Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder (1988)Obsessive-Compulsive Disorder in Children and Adolescents (1989)Anxiety Disorders of Childhood and Adolescence: A Critical Review (1991)Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder (2004)Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2008)Flumazenil Provocation of Panic Attacks (1990)Paroxetine efficacy in the treatment of generalized anxiety disorder (1997)Buspirone (1999)[18F]FDG PET Study in Obsessive–Compulsive Disorder (1995)Obsessive-compulsive disorder (2002)Pathophysiology of obsessive–compulsive disorder (2004)Monoamine Metabolites in CSF and Suicidal Behavior (1981)The Yale-Brown Obsessive Compulsive Scale (1989)Neuroanatomical abnormalities in obsessive-compulsive disorder detected with quantitative X-ray computed tomography (1988)Neurotransmitters and Suicidal Behavior (1997)
this work references cited by second hop

References

  • 1978A COMPREHENSIVE PSYCHOPATHOLOGICAL RATING SCALE1,327 cited
  • 1980Clomipramine Treatment of Obsessive-Compulsive Disorder497 cited
  • 1985Clomipramine Treatment of Childhood Obsessive-Compulsive Disorder466 cited
  • 1987Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology416 cited
  • 1987Serotonergic Responsivity in Obsessive-Compulsive Disorder370 cited
  • 1982Buspirone and diazepam in anxiety: a controlled study.308 cited
  • 2022Obsessive Compulsive Disorder306 cited
  • 1988Serotonergic Responsivity in Obsessive-Compulsive Disorder294 cited
  • 1980Clomipramine Treatment of Obsessive-Compulsive Disorder288 cited
  • 1988Serotonin Function in Obsessive-Compulsive Disorder242 cited
  • 1985The Influence of Ritanserin, a Serotonin Antagonist, in Anxiety Disorders: A Double-blind Placebo-controlled Study versus Lorazepam226 cited
  • 1987Fluvoxamine treatment of obsessive-compulsive disorder215 cited
  • 1987Biochemical Changes During Clomipramine Treatment of Childhood Obsessive-Compulsive Disorder172 cited
  • 1985Fluoxetine Treatment of Obsessive-Compulsive Disorder167 cited

Cited by

  • 1996Normal Caudate Nucleus in Obsessive-compulsive Disorder Assessed by Quantitative Neuroimaging

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

143 cited
  • 2006Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorder142 cited
  • 1991Kleptomania: clinical characteristics and associated psychopathology138 cited
  • 1994Tryptophan Depletion in Patients With Obsessive-Compulsive Disorder Who Respond to Serotonin Reuptake Inhibitors135 cited
  • 1995Alteration of Serotonin Release in the Guinea Pig Orbito-Frontal Cortex by Selective Serotonin Reuptake Inhibitors Relevance to Treatment of Obsessive-Compulsive Disorder128 cited
  • 1991Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chloro-phenylpiperazine in obsessive-compulsive disorder120 cited
  • 1991Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder114 cited
  • 1992Neurobiology of Obsessive Compulsive Disorder113 cited
  • 1992Neuroendocrine Responses to m-Chlorophenylpiperazine and i-Tryptophan in Bulimia111 cited
  • 1989Obsessive—Compulsive Disorder as a 5-HT Subsystem-Related Behavioural Disorder108 cited
  • 1992Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder107 cited
  • 2013Pharmacotherapy for trichotillomania106 cited
  • 1994Obsessive‐Compulsive Disorder105 cited
  • 1993A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to IV mCPP99 cited
  • 1993Cocaine use and other suspected risk factors for obsessive-compulsive disorder: a prospective study with data from the Epidemiologic Catchment Area surveys98 cited
  • 1997Efficacy of Fluvoxamine, Paroxetine, and Citalopram in the Treatment of Obsessive-Compulsive Disorder87 cited